Multicentric phase ii clinical trial (emn-alloric 2010) of allogenic transplantation followed by maintenance with bortezomib and lenalidomide in patients with high risk multiple myeloma
HAEMATOLOGICA（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要